Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.
Saved in:
| Title: | Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study. |
|---|---|
| Authors: | Chemaitelly, Hiam1,2 (AUTHOR) hsc2001@qatar-med.cornell.edu, Ayoub, Houssein H.3 (AUTHOR), Coyle, Peter4,5,6 (AUTHOR), Tang, Patrick7 (AUTHOR), Hasan, Mohammad R.8 (AUTHOR), Yassine, Hadi M.5,9 (AUTHOR), Al Thani, Asmaa A.5,9 (AUTHOR), Al-Kanaani, Zaina4 (AUTHOR), Al-Kuwari, Einas4 (AUTHOR), Jeremijenko, Andrew4 (AUTHOR), Kaleeckal, Anvar Hassan4 (AUTHOR), Latif, Ali Nizar4 (AUTHOR), Shaik, Riyazuddin Mohammad4 (AUTHOR), Abdul-Rahim, Hanan F.10 (AUTHOR), Nasrallah, Gheyath K.5,9 (AUTHOR), Al-Kuwari, Mohamed Ghaith11,12 (AUTHOR), Butt, Adeel A.2,4,13 (AUTHOR), Al-Romaihi, Hamad Eid14 (AUTHOR), Al-Thani, Mohamed H.14 (AUTHOR), Al-Khal, Abdullatif4 (AUTHOR) |
| Source: | BMC Infectious Diseases. 8/17/2025, Vol. 25 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
